These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


265 related items for PubMed ID: 3965588

  • 1. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations.
    Bayer AS, Lam K.
    J Infect Dis; 1985 Jan; 151(1):157-65. PubMed ID: 3965588
    [Abstract] [Full Text] [Related]

  • 2. Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis.
    Lowy FD, Wexler MA, Steigbigel NH.
    J Lab Clin Med; 1982 Jul; 100(1):94-104. PubMed ID: 6919570
    [Abstract] [Full Text] [Related]

  • 3. Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
    Galetto DW, Boscia JA, Kobasa WD, Kaye D.
    J Infect Dis; 1986 Jul; 154(1):69-75. PubMed ID: 2940303
    [Abstract] [Full Text] [Related]

  • 4. Ampicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits.
    Chambers HF, Kartalija M, Sande M.
    J Infect Dis; 1995 Apr; 171(4):897-902. PubMed ID: 7706817
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Sakoulas G, Eliopoulos GM, Alder J, Eliopoulos CT.
    Antimicrob Agents Chemother; 2003 May; 47(5):1714-8. PubMed ID: 12709345
    [Abstract] [Full Text] [Related]

  • 6. Vancomycin or vancomycin plus netilmicin for methicillin- and gentamicin-resistant Staphylococcus aureus aortic valve experimental endocarditis.
    Perdikaris G, Giamarellou H, Pefanis A, Donta I, Karayiannakos P.
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2289-94. PubMed ID: 8619584
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
    Madrigal AG, Basuino L, Chambers HF.
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus.
    Chambers HF, Xiang Q, Liu, Chow LL, Hackbarth C.
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2742-6. PubMed ID: 10543757
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin.
    Faville RJ, Zaske DE, Kaplan EL, Crossley K, Sabath LD, Quie PG.
    JAMA; 1978 Oct 27; 240(18):1963-5. PubMed ID: 249793
    [Abstract] [Full Text] [Related]

  • 11. Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and -resistant Staphylococcus aureus.
    Bayer AS, Morrison JO.
    Antimicrob Agents Chemother; 1984 Aug 27; 26(2):220-3. PubMed ID: 6567464
    [Abstract] [Full Text] [Related]

  • 12. Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci.
    Ramos MC, Ing M, Kim E, Witt MD, Bayer AS.
    Antimicrob Agents Chemother; 1996 Jan 27; 40(1):97-101. PubMed ID: 8787887
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
    Chambers HF.
    Antimicrob Agents Chemother; 2005 Mar 27; 49(3):884-8. PubMed ID: 15728879
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasone.
    Siaperas P, Pefanis A, Iliopoulos D, Katsarolis I, Kyroudi-Voulgari A, Donta I, Karayiannakos P, Giamarellou H.
    Antimicrob Agents Chemother; 2001 Dec 27; 45(12):3531-7. PubMed ID: 11709335
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis.
    Climo MW, Patron RL, Goldstein BP, Archer GL.
    Antimicrob Agents Chemother; 1998 Jun 27; 42(6):1355-60. PubMed ID: 9624475
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.